Testing

View a list of updates that were posted to MayoMedicalLaboratories.com during the month of January 2017.

By Rene Revier • February 13, 2017

Mayo Clinic physicians, genetic counselors, and allied health staff are in San Diego for the WORLDSymposium, which presents the latest information from basic science, translational research, and clinical trials for lysosomal diseases. If you are at the meeting, visit us at booth #23.

By Mayo Medical Laboratories • February 10, 2017

In January 2017, Mayo Medical Laboratories announced four new tests along with numerous reference-value changes, obsolete tests, and algorithm changes.

By Alyssa Frank • February 9, 2017

Learn more about our comprehensive testing menu as we attend MedLab 2017. If you’re attending the meeting, be sure to visit us at stand Z5.E39.

By Mayo Medical Laboratories • February 3, 2017

The Mayo Clinic Cytogenetics Laboratory recently released an updated version of the Cell-Free DNA Prenatal Screen (ID: NIPS). This test detects common chromosome abnormalities without the risk of pregnancy loss associated with invasive prenatal procedures.

By Mayo Medical Laboratories • February 3, 2017

The U.S. Food and Drug Administration recently updated its electronic filing requirements for importing goods, including biological specimens. Full enforcement of the new requirements will begin on Thursday, February 9, at 6 a.m. EST.

By Tim Brantner • February 1, 2017

The following list of updates were posted to MayoMedicalLaboratories.com during the month of December 2016.

By Rene Revier • January 19, 2017

Chromosome analysis, which was once the preferred genetic test for a wide variety of congenital abnormalities, is now one of the most frequently misordered cytogenetic tests at MML. This webinar will outline the differences in technologies and the appropriate use of each test.

By Brent Westra • January 17, 2017

In December 2016, Mayo Medical Laboratories announced four brand new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

By Alyssa Frank • January 13, 2017

A recent article in the Journal Sentinel highlights the importance of newborn screening and what can go wrong in analyzing and interpreting test results.

By Kelley Schreiber • December 27, 2016

In November 2016, Mayo Medical Laboratories announced four brand new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

By Alyssa Frank • December 15, 2016

Using targeted next-generation sequencing to identify lung tumors that may respond to targeted therapies by assessing somatic mutations simultaneously within EGFR, BRAF, KRAS, HRAS, NRAS, ALK, ERBB2 and MET and identifying rearrangements (fusions) involving ALK, ROS1, RET, and NTRK1.

By Brent Westra • December 14, 2016

The recommendations surrounding newborn screening are constantly in flux. Newly discovered treatments or emerging laboratory technologies are enabling additional recommendations for newborn screening.

By Mayo Medical Laboratories • December 12, 2016